Theralase Technologies Inc. (CVE:TLT – Get Free Report)’s share price traded down 2.6% during mid-day trading on Wednesday . The company traded as low as C$0.19 and last traded at C$0.19. 16,500 shares changed hands during mid-day trading, a decline of 85% from the average session volume of 108,074 shares. The stock had previously closed at C$0.19.
Theralase Technologies Stock Down 2.6%
The stock has a fifty day moving average price of C$0.19 and a two-hundred day moving average price of C$0.24. The company has a debt-to-equity ratio of 14.85, a quick ratio of 3.40 and a current ratio of 1.91. The firm has a market capitalization of C$45.05 million, a P/E ratio of -9.85 and a beta of 1.36.
Theralase Technologies Company Profile
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Featured Articles
- Five stocks we like better than Theralase Technologies
- What Are Growth Stocks and Investing in Them
- SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start
- What is the Dogs of the Dow Strategy? Overview and Examples
- AMD’s AI-Powered Stock Price Rally Just Shifted Gears
- What Are Some of the Best Large-Cap Stocks to Buy?
- 5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
